House Republicans, advocacy groups urge HHS to abandon measure that would restrict coverage of Biogen’s Aduhelm kdunleavy Wed, 02/09/2022 – 15:58 More: House Republicans, advocacy groups urge HHS to abandon measure that would restrict coverage of Biogen's Aduhelm Source: fierce
read moreGlaxoSmithKline’s COVID-19 antibody delivers as Nucala, Trelegy eclipse £1B landmark aliu Wed, 02/09/2022 – 11:25 More: GlaxoSmithKline's COVID-19 antibody delivers as Nucala, Trelegy eclipse £1B landmark Source: fierce
read moreTeva banks on blockbuster Austedo sales as COVID-19, Copaxone generics take their toll fkansteiner Wed, 02/09/2022 – 09:55 More: Teva banks on blockbuster Austedo sales as COVID-19, Copaxone generics take their toll Source: fierce
read moreRoche pharma CEO Anderson talks up Vabysmo’s ‘very strong launch’ plans as Eylea battle looms badams Wed, 02/09/2022 – 09:54 More: Roche pharma CEO Anderson talks up Vabysmo’s 'very strong launch' plans as Eylea battle looms Source: fierce
read moreKaryopharm ready to take new Xpovio indication to the FDA but analysts hold out for details esagonowsky Wed, 02/09/2022 – 08:46 More: Karyopharm ready to take new Xpovio indication to the FDA but analysts hold out for details Source: fierce
read moreSMC accepts promising new therapy which offers a better quality of life to patients with epilepsy More: Angelini Pharma’s Ontozry available for patients in Scotland with drug-resistant epilepsy Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals